Abstract
The tissue-specific Wilms' tumor gene WT1 is expressed in a range of acute leukemias and hematopoietic cell lines. Using single-strand conformational polymorphism analysis, we have found mutations in the WT1 gene in 4 of 36 acute leukemias. WT1 mutations are found in 15% of cases of acute myeloid leukemia, in which they are associated with a poor response to chemotherapy. The mutations comprise small insertions in exons 1 and 7 and a nonsense mutation in exon 9. All are predicted to produce a truncated WT1 protein with absence or disruption of the zinc finger region. These are the first mutations in the WT1 gene to be described in sporadic leukemia.
Publication types
-
Case Reports
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Acute Disease
-
Adolescent
-
Adult
-
Amino Acid Sequence
-
Base Sequence
-
Cells, Cultured
-
Child
-
DNA Mutational Analysis
-
DNA, Neoplasm / genetics*
-
DNA-Binding Proteins / biosynthesis
-
DNA-Binding Proteins / genetics
-
Exons / genetics
-
Fatal Outcome
-
Female
-
Genes, Wilms Tumor*
-
Hematopoietic Stem Cells / metabolism
-
Humans
-
Leukemia / classification
-
Leukemia / genetics*
-
Leukemia / mortality
-
Male
-
Molecular Sequence Data
-
Mutation*
-
Polymorphism, Single-Stranded Conformational
-
Prognosis
-
RNA, Neoplasm / genetics
-
Transcription Factors / biosynthesis
-
Transcription Factors / genetics
-
WT1 Proteins
-
Zinc Fingers / genetics
Substances
-
DNA, Neoplasm
-
DNA-Binding Proteins
-
RNA, Neoplasm
-
Transcription Factors
-
WT1 Proteins